After raising VC money weeks ago, Unity tacks on an $85M IPO; Abpro sets terms for $60M IPO
→ Unity Biotechnology has pulled off its leap of faith, pocketing an $85 million IPO with a case built on preclinical data. The anti-aging drug …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
